Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Prazosin for Treatment of Patients With Alcohol Dependence (AD) and Post Traumatic Stress Disorder (PTSD).

NCT00744055 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT00744055
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00744055 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Prazosin for Treatment of Patients With Alcohol Dependence (AD) and Post Traumatic Stress Disorder (PTSD).
Lead sponsor
Yale University
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2009
Completion date
October 31, 2014
Enrollment
96 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol dependence, stress disorders, post-traumatic